Strategia starts phase 1 trial of FF-10502 in patients with advanced cancers
The trial is being performed under the direction of Drs. Filip Janku, M.D. and Gerald Falchook, M.D. as Co-Principal Investigators. Dr. Janku is Assistant Professor in the Department